Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 918

1.

Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel.

Fukuda N, Takahari D, Wakatsuki T, Osumi H, Nakayama I, Matsushima T, Ichimura T, Ogura M, Ozaka M, Suenaga M, Shinozaki E, Chin K, Yamaguchi K.

Oncotarget. 2018 Mar 8;9(20):15219-15227. doi: 10.18632/oncotarget.24635. eCollection 2018 Mar 16.

2.

The effect of near-infrared fluorescence conjugation on the anti-cancer potential of cetuximab.

Yun JY, Hyun BH, Nam SY, Yun YW, Lee HJ, Lee BJ.

Lab Anim Res. 2018 Mar;34(1):30-36. doi: 10.5625/lar.2018.34.1.30. Epub 2018 Mar 22.

3.

Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis.

Peng H, Tang LL, Liu X, Chen L, Li WF, Mao YP, Zhang Y, Liu LZ, Tian L, Guo Y, Sun Y, Ma J.

BMC Cancer. 2018 Mar 27;18(1):323. doi: 10.1186/s12885-018-4268-y.

4.

Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities.

Porru M, Pompili L, Caruso C, Biroccio A, Leonetti C.

J Exp Clin Cancer Res. 2018 Mar 13;37(1):57. doi: 10.1186/s13046-018-0719-1.

5.

NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.

Schirripa M, Zhang W, Yang D, Cao S, Okazaki S, Loupakis F, Berger MD, Ning Y, Miyamoto Y, Suenaga M, Alberti G, West JD, Lonardi S, Khoukaz T, Bergamo F, Battaglin F, Antoniotti C, Falcone A, Stintzing S, Heinemann V, Lenz HJ.

PLoS One. 2018 Mar 9;13(3):e0193640. doi: 10.1371/journal.pone.0193640. eCollection 2018.

6.

Near infrared fluorescence imaging of EGFR expression in vivo using IRDye800CW-nimotuzumab.

Bernhard W, El-Sayed A, Barreto K, Gonzalez C, Hill W, Parada AC, Fonge H, Geyer CR.

Oncotarget. 2017 Dec 21;9(5):6213-6227. doi: 10.18632/oncotarget.23557. eCollection 2018 Jan 19.

7.

Kinase-targeted cancer therapies: progress, challenges and future directions.

Bhullar KS, Lagarón NO, McGowan EM, Parmar I, Jha A, Hubbard BP, Rupasinghe HPV.

Mol Cancer. 2018 Feb 19;17(1):48. doi: 10.1186/s12943-018-0804-2. Review.

8.

Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection.

Viala M, Vinches M, Alexandre M, Mollevi C, Durigova A, Hayaoui N, Homicsko K, Cuenant A, Gongora C, Gianni L, Tosi D.

Br J Cancer. 2018 Mar 6;118(5):679-697. doi: 10.1038/bjc.2017.473. Epub 2018 Feb 13.

PMID:
29438365
9.

MicroRNA-9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A-2.

Xue F, Liang Y, Li Z, Liu Y, Zhang H, Wen Y, Yan L, Tang Q, Xiao E, Zhang D.

Oncol Lett. 2018 Jan;15(1):813-820. doi: 10.3892/ol.2017.7399. Epub 2017 Nov 14.

10.

Phosphorylation of Ser6 in hnRNPA1 by S6K2 regulates glucose metabolism and cell growth in colorectal cancer.

Sun Y, Luo M, Chang G, Ren W, Wu K, Li X, Shen J, Zhao X, Hu Y.

Oncol Lett. 2017 Dec;14(6):7323-7331. doi: 10.3892/ol.2017.7085. Epub 2017 Sep 27.

11.

Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC.

Tang XM, Chen H, Li Q, Song Y, Zhang S, Xu XS, Xu Y, Chen S.

Onco Targets Ther. 2017 Dec 28;11:123-129. doi: 10.2147/OTT.S149716. eCollection 2018.

12.

Trends in colorectal cancer mortality in hispanics: a SEER analysis.

Barzi A, Yang D, Mostofizadeh S, Lenz HJ.

Oncotarget. 2017 Oct 19;8(65):108771-108777. doi: 10.18632/oncotarget.21938. eCollection 2017 Dec 12.

13.

Combination chemotherapy with Regorafenib in metastatic colorectal cancer treatment: A single center, retrospective study.

Lin CY, Lin TH, Chen CC, Chen MC, Chen CP.

PLoS One. 2018 Jan 5;13(1):e0190497. doi: 10.1371/journal.pone.0190497. eCollection 2018.

14.

Therapeutic strategies against cancer stem cells in human colorectal cancer.

Szaryńska M, Olejniczak A, Kobiela J, Spychalski P, Kmieć Z.

Oncol Lett. 2017 Dec;14(6):7653-7668. doi: 10.3892/ol.2017.7261. Epub 2017 Oct 23.

15.

Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?

Chae YK, Arya A, Chiec L, Shah H, Rosenberg A, Patel S, Raparia K, Choi J, Wainwright DA, Villaflor V, Cristofanilli M, Giles F.

Oncotarget. 2017 Aug 1;8(59):100863-100898. doi: 10.18632/oncotarget.19809. eCollection 2017 Nov 21. Review.

16.

Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial.

Pugh S, Thiébaut R, Bridgewater J, Grisoni ML, Moutasim K, Rousseau F, Thomas GJ, Griffiths G, Liebaert F, Primrose J, Laurent-Puig P.

Oncotarget. 2017 Sep 27;8(55):93856-93866. doi: 10.18632/oncotarget.21291. eCollection 2017 Nov 7.

17.

Comprehensive genomic sequencing detects important genetic differences between right-sided and left-sided colorectal cancer.

Shimada Y, Kameyama H, Nagahashi M, Ichikawa H, Muneoka Y, Yagi R, Tajima Y, Okamura T, Nakano M, Sakata J, Kobayashi T, Nogami H, Maruyama S, Takii Y, Hayashida T, Takaishi H, Kitagawa Y, Oki E, Konishi T, Ishida F, Kudo SE, Ring JE, Protopopov A, Lyle S, Ling Y, Okuda S, Ishikawa T, Akazawa K, Takabe K, Wakai T.

Oncotarget. 2017 Aug 24;8(55):93567-93579. doi: 10.18632/oncotarget.20510. eCollection 2017 Nov 7.

18.

Hepatic Metastasis from Colorectal Cancer.

Valderrama-Treviño AI, Barrera-Mera B, Ceballos-Villalva JC, Montalvo-Javé EE.

Euroasian J Hepatogastroenterol. 2017 Jul-Dec;7(2):166-175. doi: 10.5005/jp-journals-10018-1241. Epub 2017 Sep 29.

19.

Peptides as Therapeutic Agents for Dengue Virus.

Chew MF, Poh KS, Poh CL.

Int J Med Sci. 2017 Oct 15;14(13):1342-1359. doi: 10.7150/ijms.21875. eCollection 2017. Review.

20.

Chk1 inhibitor SCH 900776 enhances the antitumor activity of MLN4924 on pancreatic cancer.

Li JA, Song C, Rong Y, Kuang T, Wang D, Xu X, Yuan J, Luo K, Qin B, Nowsheen S, Lou Z, Lou W.

Cell Cycle. 2018;17(2):191-199. doi: 10.1080/15384101.2017.1405194. Epub 2018 Jan 3.

PMID:
29157102

Supplemental Content

Support Center